Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Director Buys $16,430.00 in Stock

Sabra Health Care REIT, Inc. (NASDAQ:SBRA - Get Free Report) Director Catherine Cusack purchased 1,000 shares of the firm's stock in a transaction on Friday, February 21st. The stock was bought at an average cost of $16.43 per share, with a total value of $16,430.00. Following the acquisition, the director now owns 59,083 shares of the company's stock, valued at approximately $970,733.69. The trade was a 1.72 % increase in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website.

Catherine Cusack also recently made the following trade(s):

• On Monday, February 24th, Catherine Cusack purchased 1,500 shares of Sabra Health Care REIT stock. The stock was bought at an average cost of $15.92 per share, with a total value of $23,880.00.

Sabra Health Care REIT Stock Performance

Shares of NASDAQ:SBRA traded up $0.16 during midday trading on Friday, reaching $16.61. The company's stock had a trading volume of 2,969,923 shares, compared to its average volume of 2,086,993. The firm has a market capitalization of $3.95 billion, a PE ratio of 31.34, a P/E/G ratio of 1.97 and a beta of 1.25. Sabra Health Care REIT, Inc. has a twelve month low of $13.31 and a twelve month high of $20.03. The stock has a fifty day moving average of $16.77 and a 200 day moving average of $17.61. The company has a quick ratio of 4.16, a current ratio of 4.32 and a debt-to-equity ratio of 0.88.

Remove Ads

Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) last released its quarterly earnings results on Wednesday, February 19th. The real estate investment trust reported $0.36 EPS for the quarter, meeting the consensus estimate of $0.36. The company had revenue of $182.35 million for the quarter, compared to analyst estimates of $178.01 million. Sabra Health Care REIT had a net margin of 18.02% and a return on equity of 4.60%. On average, equities analysts expect that Sabra Health Care REIT, Inc. will post 1.45 EPS for the current fiscal year.

Sabra Health Care REIT Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, February 28th. Investors of record on Friday, February 14th were given a dividend of $0.30 per share. The ex-dividend date was Friday, February 14th. This represents a $1.20 annualized dividend and a yield of 7.22%. Sabra Health Care REIT's dividend payout ratio is presently 226.42%.

Institutional Trading of Sabra Health Care REIT

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. VSM Wealth Advisory LLC acquired a new stake in Sabra Health Care REIT during the fourth quarter valued at $26,000. Quarry LP acquired a new stake in Sabra Health Care REIT during the third quarter valued at $30,000. Assetmark Inc. grew its position in Sabra Health Care REIT by 168.4% during the third quarter. Assetmark Inc. now owns 1,962 shares of the real estate investment trust's stock valued at $37,000 after buying an additional 1,231 shares during the period. Wilmington Savings Fund Society FSB acquired a new stake in shares of Sabra Health Care REIT in the third quarter valued at about $59,000. Finally, Harbor Capital Advisors Inc. acquired a new stake in shares of Sabra Health Care REIT in the third quarter valued at about $78,000. Institutional investors and hedge funds own 99.40% of the company's stock.

Analyst Ratings Changes

A number of research firms have issued reports on SBRA. Mizuho reaffirmed a "neutral" rating and issued a $20.00 price target on shares of Sabra Health Care REIT in a report on Thursday, December 5th. JMP Securities raised shares of Sabra Health Care REIT from a "market perform" rating to an "outperform" rating and set a $20.00 price target for the company in a report on Tuesday, January 7th. Truist Financial lowered shares of Sabra Health Care REIT from a "buy" rating to a "hold" rating and cut their price objective for the stock from $18.00 to $17.00 in a research note on Friday, January 17th. Finally, Citizens Jmp upgraded shares of Sabra Health Care REIT from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, January 7th. Three investment analysts have rated the stock with a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $19.17.

Sabra Health Care REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.